Industries > Pharma > Telemedicine Devices Market 2018-2028

Telemedicine Devices Market 2018-2028

Forecasts and Analysis by Device Type (Telemonitors, Peripheral Devices). Peripheral Devices (Blood Pressure Monitors, Blood Glucose Monitors, Weighing Scales, Pulse Oximeters, Peak Flow Meters, Others) and Geography, with Profiles of Leading Companies

PUBLISHED: 09 February 2018
PAGES: 153
PRODUCT CODE: PHA0285

Clear
WOOCS 2.2.1
SKU: PHA0285 Categories: , ,

• Do you need definitive Telemedicine Devices market data?
• Succinct Telemedicine Devices market analysis?
• Technological insight?
• Actionable business recommendations?

Read on to discover how this definitive report can transform your own research and save you time.

The Global Telemedicine Devices market shows immense potential to grow in the future, growing in line with some emerging trends. One such trend is the increasing strategic partnerships in a move to introduce or diversify product portfolios pertaining to the delivery of healthcare.

It is estimated that in 2025, an estimated 1.56 billion adults will be living with hypertension. Telemedicine can help in better management of these diseases as well as help to reduce associated cost. The sickness, disability or death associated with chronic disease can be avoided through preventive measures and use of telemedicine. Moreover, when an older person is diagnosed with a chronic disorder, there is feeling of a loss of freedom and autonomy. Telemedicine can offer a good quality life for such patients at home.

Report highlights

• 88 quantitative tables, charts, and graphs across 153 pages

• Global Telemedicine Devices market outlook and analysis from 2018-2028

• Global Telemedicine Devices submarket forecasts and analysis from 2018-2028
• Telemonitors 
• Peripheral Devices:
– Blood Pressure Monitors
– Blood Glucose Monitors
– Weighing Scales
– Pulse Oximeters
– Peak Flow Meters
– Other Devices

• Key National Telemedicine Devices market forecasts 2018-2028
• US forecast 2018-2028
• Germany forecast 2018-2028
• UK forecast 2018-2028
• France forecast 2018-2028
• Italy forecast 2018-2028
• Spain forecast 2018-2028
• Japan forecast 2018-2028
• Brazil forecast 2018-2028
• Russia forecast 2018-2028
• India forecast 2018-2028
• China forecast 2018-2028
• Brazil forecast 2018-2028

Telemedicine Devices Market 2018-2028

Key questions answered 
• What does the future hold for the Pharmaceutical industry with regards to Telemedicine Devices
• Where should you target your business strategy?
• Which applications should you focus upon?
• Which disruptive technologies should you invest in?
• Which companies should you form strategic alliances with?
• Which company is likely to success and why?
• What business models should you adopt?
• What industry trends should you be aware of?

Target audience
• Leading Pharmaceutical companies
• Suppliers
• Contractors
• Technologists
• R&D staff
• Consultants
• Analysts
• CEO’s
• CIO’s
• COO’s
• Business development managers
• Investors
• Governments
• Agencies
• Banks

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Telemedicine Devices Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Telemedicine Devices Market 2018-2028


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories